Cargando…

US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic

BACKGROUND: During the 2009 H1N1 pandemic, the global health community sought to make vaccine available “in developing nations in the same timeframe as developed nations.” However, richer nations placed advance orders with manufacturers, leaving poorer nations dependent on the quantity and timing of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Supriya, Quinn, Sandra Crouse, Kim, Kevin H., Hilyard, Karen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295778/
https://www.ncbi.nlm.nih.gov/pubmed/22412979
http://dx.doi.org/10.1371/journal.pone.0033025
_version_ 1782225639907000320
author Kumar, Supriya
Quinn, Sandra Crouse
Kim, Kevin H.
Hilyard, Karen M.
author_facet Kumar, Supriya
Quinn, Sandra Crouse
Kim, Kevin H.
Hilyard, Karen M.
author_sort Kumar, Supriya
collection PubMed
description BACKGROUND: During the 2009 H1N1 pandemic, the global health community sought to make vaccine available “in developing nations in the same timeframe as developed nations.” However, richer nations placed advance orders with manufacturers, leaving poorer nations dependent on the quantity and timing of vaccine donations by manufacturers and rich nations. Knowledge of public support for timely donations could be important to policy makers during the next pandemic. We explored what the United States (US) public believes about vaccine donation by its country to poorer countries. METHODS AND FINDINGS: We surveyed 2079 US adults between January 22(nd) and February 1(st) 2010 about their beliefs regarding vaccine donation to poorer countries. Income (p = 0.014), objective priority status (p = 0.005), nativity, party affiliation, and political ideology (p<0.001) were significantly related to views on the amount of vaccine to be donated. Though party affiliation and political ideology were related to willingness to donate vaccine (p<0.001), there was bipartisan support for timely donations of 10% of the US vaccine supply so that those “at risk in poorer countries can get the vaccine at the same time” as those at risk in the US. CONCLUSIONS: We suggest that the US and other developed nations would do well to bolster support with education and public discussion on this issue prior to an emerging pandemic when emotional reactions could potentially influence support for donation. We conclude that given our evidence for bipartisan support for timely donations, it may be necessary to design multiple arguments, from utilitarian to moral, to strengthen public and policy makers' support for donations.
format Online
Article
Text
id pubmed-3295778
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32957782012-03-12 US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic Kumar, Supriya Quinn, Sandra Crouse Kim, Kevin H. Hilyard, Karen M. PLoS One Research Article BACKGROUND: During the 2009 H1N1 pandemic, the global health community sought to make vaccine available “in developing nations in the same timeframe as developed nations.” However, richer nations placed advance orders with manufacturers, leaving poorer nations dependent on the quantity and timing of vaccine donations by manufacturers and rich nations. Knowledge of public support for timely donations could be important to policy makers during the next pandemic. We explored what the United States (US) public believes about vaccine donation by its country to poorer countries. METHODS AND FINDINGS: We surveyed 2079 US adults between January 22(nd) and February 1(st) 2010 about their beliefs regarding vaccine donation to poorer countries. Income (p = 0.014), objective priority status (p = 0.005), nativity, party affiliation, and political ideology (p<0.001) were significantly related to views on the amount of vaccine to be donated. Though party affiliation and political ideology were related to willingness to donate vaccine (p<0.001), there was bipartisan support for timely donations of 10% of the US vaccine supply so that those “at risk in poorer countries can get the vaccine at the same time” as those at risk in the US. CONCLUSIONS: We suggest that the US and other developed nations would do well to bolster support with education and public discussion on this issue prior to an emerging pandemic when emotional reactions could potentially influence support for donation. We conclude that given our evidence for bipartisan support for timely donations, it may be necessary to design multiple arguments, from utilitarian to moral, to strengthen public and policy makers' support for donations. Public Library of Science 2012-03-06 /pmc/articles/PMC3295778/ /pubmed/22412979 http://dx.doi.org/10.1371/journal.pone.0033025 Text en Kumar et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kumar, Supriya
Quinn, Sandra Crouse
Kim, Kevin H.
Hilyard, Karen M.
US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic
title US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic
title_full US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic
title_fullStr US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic
title_full_unstemmed US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic
title_short US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic
title_sort us public support for vaccine donation to poorer countries in the 2009 h1n1 pandemic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295778/
https://www.ncbi.nlm.nih.gov/pubmed/22412979
http://dx.doi.org/10.1371/journal.pone.0033025
work_keys_str_mv AT kumarsupriya uspublicsupportforvaccinedonationtopoorercountriesinthe2009h1n1pandemic
AT quinnsandracrouse uspublicsupportforvaccinedonationtopoorercountriesinthe2009h1n1pandemic
AT kimkevinh uspublicsupportforvaccinedonationtopoorercountriesinthe2009h1n1pandemic
AT hilyardkarenm uspublicsupportforvaccinedonationtopoorercountriesinthe2009h1n1pandemic